Short Interest in Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) Decreases By 24.4%

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) was the recipient of a significant drop in short interest in the month of December. As of December 15th, there was short interest totaling 4,651 shares, a drop of 24.4% from the November 30th total of 6,151 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.

Shanghai Fosun Pharmaceutical (Group) Trading Up 0.4%

SFOSF opened at $2.78 on Wednesday. Shanghai Fosun Pharmaceutical has a 52-week low of $1.62 and a 52-week high of $3.50. The company has a 50 day moving average of $3.22 and a two-hundred day moving average of $2.80.

About Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) Co, Ltd. is a China‐based healthcare company and a core subsidiary of Fosun International. The company operates across drug manufacturing, distribution and retail services, and health management. Its product portfolio includes generic and proprietary small‐molecule drugs, bio‐pharmaceuticals, vaccines and traditional Chinese patent medicines. Through integrated R&D capabilities and strategic partnerships, Fosun Pharmaceutical pursues innovation across therapeutic areas such as oncology, cardiovascular, metabolic and infectious diseases.

The pharmaceutical manufacturing segment encompasses chemical pharmaceuticals, Chinese patent medicines and biological products, while the distribution arm manages one of the largest drug distribution networks in China, supplying hospitals, clinics and retail pharmacies.